Search/
Company exports
CSV downloadsPro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
Foundry·2303.TW
United Microelectronics Corporation
TAI · TW
Pure-play foundry supplying mature and specialty logic, mixed-signal, RF, high-voltage, and embedded memory process capacity.
AI relevance
Mature-node foundry capacity for controllers, power management, connectivity, and support chips used around AI systems.
Price
$145.50
Change
+5.50 (+3.93%)
Market cap
$1.83T
52w range
$40–$156
Exchange
TAI
Country
TW
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Price chart
2303.TW market performance
Daily close for United Microelectronics Corporation
- Latest close
- $145.5
- Range move
- +$97.20 (+201.2%)
- Range high
- $146.0
- Range low
- $40.40
- Latest volume
- 295.4M
- Source
- FMP EOD
Downloads
CSVExports
Download statements, ratios, chart data, and transcript indexes.
Income statement
12 annual rowsRevenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Balance sheet
12 annual rowsCash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Cash flow
12 annual rowsOperating cash flow, capital expenditures, and free cash flow.
Key metrics
12 annual rowsEnterprise value, valuation multiples, returns, yields, and cash conversion.
Ratios
12 annual rowsMargins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Chart data
1225 rowsFive years of daily close and volume data powering the company chart.
Transcript list
77 rowsAvailable earnings-call transcript dates by fiscal year and quarter.
StreetHold
Analyst expectations
Rating consensus14 ratings
Strong buy
0
Buy
4
Hold
7
Sell
3
Strong sell
0
Annual estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $274.56B | $253.94B - $298.28B | $4.64 | $4.12 - $5.59 | $133.16B | $77.37B | $56.22B | $13.09B | 20 rev / 20 EPS |
| 2027-12-31 | $316.43B | $270.47B - $400.06B | $5.49 | $4.05 - $8.47 | $153.47B | $89.17B | $67.58B | $15.08B | 22 rev / 19 EPS |
| 2028-12-31 | $344.22B | $343.52B - $344.92B | $6.52 | $4.32 - $10.48 | $166.95B | $97.00B | $84.17B | $16.41B | 13 rev / 11 EPS |
Quarterly estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $67.41B | $63.26B - $69.01B | $1.01 | $0.85 - $1.41 | $32.69B | $19.00B | $12.71B | $3.21B | 14 rev / 16 EPS |
| 2026-09-30 | $71.97B | $64.68B - $79.97B | $1.17 | $1.00 - $1.53 | $34.91B | $20.28B | $14.68B | $3.43B | 14 rev / 16 EPS |
| 2026-12-31 | $73.60B | $67.56B - $78.67B | $1.18 | $1.06 - $1.29 | $35.70B | $20.74B | $14.89B | $3.51B | 11 rev / 14 EPS |
| 2027-03-31 | $72.78B | $66.81B - $77.79B | $1.21 | $1.08 - $1.32 | $35.30B | $20.51B | $15.23B | $3.47B | 11 rev / 10 EPS |
| 2027-06-30 | $76.80B | $70.49B - $82.08B | $1.35 | $1.20 - $1.47 | $37.25B | $21.64B | $16.96B | $3.66B | 7 rev / 7 EPS |
| 2027-09-30 | $82.08B | $75.35B - $87.73B | $1.49 | $1.33 - $1.62 | $39.81B | $23.13B | $18.75B | $3.91B | 8 rev / 7 EPS |
| 2027-12-31 | $80.77B | $74.14B - $86.33B | $1.48 | $1.32 - $1.61 | $39.17B | $22.76B | $18.59B | $3.85B | 7 rev / 14 EPS |
| 2028-03-31 | $79.50B | $72.97B - $84.97B | $1.51 | $1.35 - $1.64 | $38.56B | $22.40B | $18.99B | $3.79B | 6 rev / 11 EPS |
Price target history
No price target summary on file.
Latest grade actions
| Date | Firm | Action | Previous | New |
|---|---|---|---|---|
| 2021-06-07 | Bernstein | Downgrade | Market Perform | Underperform |
| 2020-02-04 | China Renaissance | Upgrade | Hold | Buy |
| 2019-11-25 | Citi | Upgrade | Sell | Neutral |
| 2019-11-24 | Citigroup | Upgrade | Sell | Neutral |
| 2019-10-30 | Goldman Sachs | Upgrade | Sell | Neutral |
| 2019-01-23 | HSBC | Downgrade | Buy | Hold |
| 2018-11-15 | Morgan Stanley | Downgrade | Equal Weight | Underweight |
| 2018-11-06 | UBS | Downgrade | Buy | Neutral |
Historical rating snapshots
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 4 | 3 | 11 | 2 | 4 |
| 2026-05-01 | 4 | 3 | 13 | 2 | 4 |
| 2026-04-01 | 4 | 3 | 13 | 3 | 4 |
| 2026-03-01 | 4 | 2 | 12 | 3 | 4 |
| 2026-02-01 | 4 | 2 | 12 | 4 | 4 |
| 2026-01-01 | 5 | 2 | 12 | 4 | 4 |
| 2025-12-01 | 5 | 2 | 13 | 3 | 2 |
| 2025-11-01 | 5 | 3 | 13 | 2 | 2 |
FinancialsFY 2025
Financials
Income statement annual
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $237.55B | $68.91B | 29.0% | $17.73B | $41.96B | $108.91B | $41.72B | $3.34 |
| FY 2024 | $232.30B | $75.65B | 32.6% | $15.62B | $51.61B | $106.89B | $47.21B | $3.80 |
| FY 2023 | $222.53B | $77.74B | 34.9% | $13.28B | $57.89B | $105.85B | $60.99B | $4.93 |
| FY 2022 | $278.71B | $125.76B | 45.1% | $12.95B | $104.29B | $153.72B | $89.48B | $7.09 |
| FY 2021 | $213.01B | $72.05B | 33.8% | $12.93B | $51.69B | $102.08B | $51.25B | $4.57 |
| FY 2020 | $176.82B | $39.00B | 22.1% | $12.90B | $22.01B | $71.97B | $22.86B | $2.42 |
| FY 2019 | $148.20B | $21.31B | 14.4% | $11.86B | $4.88B | $56.71B | $8.16B | $0.71 |
| FY 2018 | $151.25B | $22.84B | 15.1% | $13.03B | $5.68B | $57.58B | $7.68B | $0.58 |
| FY 2017 | $149.28B | $27.06B | 18.1% | $13.67B | $6.57B | $62.98B | $9.63B | $0.81 |
| FY 2016 | $147.87B | $30.38B | 20.5% | $13.53B | $6.19B | $58.34B | $8.62B | $0.71 |
| FY 2015 | $144.83B | $31.77B | 21.9% | $12.17B | $10.84B | $57.23B | $13.25B | $1.08 |
| FY 2014 | $140.01B | $31.85B | 22.7% | $13.66B | $10.08B | $51.25B | $11.11B | $0.90 |
Cash flow annual
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $99.86B | $47.74B | $52.12B |
| FY 2024 | $93.87B | $88.54B | $2.53B |
| FY 2023 | $86.00B | $91.47B | -$8.02B |
| FY 2022 | $145.86B | $82.88B | $62.98B |
| FY 2021 | $90.35B | $49.96B | $40.39B |
| FY 2020 | $65.75B | $28.35B | $37.39B |
| FY 2019 | $54.90B | $18.96B | $35.94B |
| FY 2018 | $50.93B | $20.43B | $30.51B |
| FY 2017 | $52.47B | $45.52B | $6.95B |
| FY 2016 | $46.45B | $93.11B | -$46.66B |
| FY 2015 | $60.04B | $61.59B | -$1.55B |
| FY 2014 | $44.79B | $44.39B | $397.9M |
Balance sheet annual
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $128.37B | $34.50B | $37.23B | $278.87B | $579.00B | $59.78B | -$50.88B | $193.66B | $379.77B |
| FY 2024 | $115.24B | $35.70B | $35.78B | $292.03B | $560.17B | $70.47B | -$34.53B | $194.46B | $365.45B |
| FY 2023 | $144.88B | $33.16B | $35.71B | $250.85B | $559.19B | $80.17B | -$52.39B | $197.78B | $359.24B |
| FY 2022 | $178.60B | $39.20B | $31.07B | $198.03B | $524.65B | $53.20B | -$120.62B | $201.83B | $322.47B |
| FY 2021 | $170.90B | $36.37B | $23.01B | $145.39B | $450.96B | $46.82B | -$85.80B | $186.58B | $264.15B |
| FY 2020 | $109.57B | $29.24B | $22.55B | $141.11B | $377.52B | $41.41B | -$52.64B | $141.74B | $235.66B |
| FY 2019 | $98.57B | $26.70B | $21.71B | $158.88B | $370.19B | $65.93B | -$29.56B | $162.97B | $202.50B |
| FY 2018 | $84.19B | $24.70B | $18.20B | $173.51B | $364.60B | $80.19B | -$3.47B | $158.07B | $206.07B |
| FY 2017 | $82.39B | $22.14B | $18.26B | $206.03B | $394.10B | $78.76B | -$2.91B | $180.06B | $208.66B |
| FY 2016 | $58.29B | $24.00B | $17.00B | $226.16B | $386.66B | $81.28B | $23.70B | $167.91B | $212.78B |
| FY 2015 | $53.96B | $19.99B | $17.64B | $188.77B | $337.37B | $53.03B | -$261.0M | $108.55B | $222.83B |
| FY 2014 | $46.44B | $23.06B | $15.24B | $167.75B | $313.25B | $39.65B | -$6.05B | $88.24B | $221.16B |
Annual ratios and key metrics
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 29.0% | 17.7% | 17.6% | 2.3x | 1.9x | 11.0% | 7.0% | 2.4x | 5.2x | 8.5% | 7.5% | 114d |
| FY 2024 | 32.6% | 22.2% | 20.3% | 2.5x | 2.0x | 12.9% | 8.8% | 2.1x | 4.6x | 0.5% | 6.7% | 122d |
| FY 2023 | 34.9% | 26.0% | 27.4% | 2.2x | 1.8x | 17.0% | 10.2% | 2.6x | 5.5x | -1.3% | 6.0% | 125d |
| FY 2022 | 45.1% | 37.4% | 32.1% | 2.2x | 2.0x | 27.7% | 20.4% | 1.4x | 2.5x | 12.6% | 4.6% | 104d |
| FY 2021 | 33.8% | 24.3% | 24.1% | 2.2x | 1.9x | 19.4% | 12.9% | 3.3x | 6.9x | 5.1% | 6.1% | 100d |
| FY 2020 | 22.1% | 12.4% | 12.9% | 2.1x | 1.8x | 9.7% | 6.5% | 2.9x | 7.2x | 6.6% | 7.3% | 99d |
| FY 2019 | 14.4% | 3.3% | 5.5% | 2.1x | 1.8x | 4.0% | 1.5% | 1.1x | 2.9x | 18.5% | 8.0% | 103d |
| FY 2018 | 15.1% | 3.8% | 5.1% | 2.8x | 2.5x | 3.7% | 1.7% | 0.9x | 2.4x | 21.5% | 8.6% | 92d |
| FY 2017 | 18.1% | 4.4% | 6.4% | 1.6x | 1.4x | 4.6% | 1.6% | 1.1x | 2.7x | 4.1% | 9.2% | 89d |
| FY 2016 | 20.5% | 4.2% | 5.8% | 1.5x | 1.3x | 4.1% | 1.6% | 1.1x | 2.8x | -33.8% | 9.2% | 91d |
| FY 2015 | 21.9% | 7.5% | 9.2% | 1.9x | 1.6x | 5.9% | 3.3% | 1.0x | 2.6x | -1.0% | 8.4% | 88d |
| FY 2014 | 22.7% | 7.2% | 7.9% | 2.0x | 1.7x | 5.0% | 2.8% | 1.3x | 3.4x | 0.2% | 9.8% | 91d |
Annual growth
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | +2.3% | -8.9% | +13.5% | -18.7% | -11.6% | -12.1% | +1960.8% | +47.7% | +11.4% | +4.0% | +3.4% | -15.2% |
| FY 2024 | +4.4% | -2.7% | +17.6% | -10.8% | -22.6% | -22.9% | +131.5% | +2.8% | -20.5% | +0.2% | +0.2% | -12.1% |
| FY 2023 | -20.2% | -38.2% | +2.5% | -44.5% | -31.8% | -30.5% | -112.7% | -13.4% | -18.9% | +14.9% | +6.6% | +50.7% |
| FY 2022 | +30.8% | +74.6% | +0.1% | +101.8% | +74.6% | +55.1% | +55.9% | -65.9% | +4.5% | +35.0% | +16.3% | +13.6% |
| FY 2021 | +20.5% | +84.8% | +0.3% | +134.9% | +124.2% | +88.8% | +8.0% | -76.2% | +56.0% | +2.0% | +19.5% | +13.1% |
| FY 2020 | +19.3% | +83.0% | +8.7% | +350.6% | +180.3% | +240.8% | +4.0% | -49.5% | +11.2% | +3.9% | +2.0% | -37.2% |
| FY 2019 | -2.0% | -6.7% | -8.9% | -14.0% | +6.2% | +22.4% | +17.8% | +7.2% | +17.1% | +19.3% | +1.5% | -17.8% |
| FY 2018 | +1.3% | -15.6% | -4.7% | -13.5% | -20.3% | -28.4% | +338.7% | +55.1% | +2.2% | -0.3% | -7.5% | +1.8% |
| FY 2017 | +1.0% | -10.9% | +1.0% | +6.1% | +11.7% | +14.1% | +114.9% | +51.1% | +41.3% | +7.4% | +1.9% | -3.1% |
| FY 2016 | +2.1% | -4.4% | +11.2% | -42.8% | -35.0% | -34.3% | -2911.4% | -51.2% | +8.0% | -3.6% | +14.6% | +53.3% |
| FY 2015 | +3.4% | -0.3% | -10.9% | +7.5% | +19.3% | +20.0% | -489.5% | -38.8% | +16.2% | +15.7% | +7.7% | +33.7% |
| FY 2014 | +13.1% | +35.2% | +9.4% | +149.9% | -12.0% | -10.9% | -94.8% | -24.0% | -13.4% | +8.9% | +5.9% | +19.9% |
Segments
Revenue Mix
Revenue segmentation data unavailable.
Transcripts77 on file
Transcripts
Events
Events
Next earnings
2026-07-29EPS est $1.01